Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ga-68-CXCR4 PET/CT in Detecting, Evaluating Response to Treatment, and Monitoring Risk of Aggressiveness of Indolent B-cell Lymphoma

NCT06461182 is registered in ClinicalTrials.gov with Koo Foundation Sun Yat-Sen Cancer Center as lead sponsor.

NCT NCT06461182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06461182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ga-68-CXCR4 PET/CT in Detecting, Evaluating Response to Treatment, and Monitoring Risk of Aggressiveness of Indolent B-cell Lymphoma
Lead sponsor
Koo Foundation Sun Yat-Sen Cancer Center
Phase
Phase 2
Overall status
Recruiting
Start date
April 29, 2024
Completion date
April 30, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

indolent b-cell non-hodgkin lymphoma